New Horizon Health
IPONew Horizon Health Center | Community Health Center
Public · Hangzhou, China · Founded 2015 · $136.0M raised
- Headquarters
- Hangzhou, Texas
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- newhorizonhc.org
- Total Funding
- $136.0M
- Last Round
- $30.0M Series EJul 2020
- Rounds
- 4
- Type
- Public
About
New Horizon Health (诺辉健康) is the pioneer and leader in China's cancer screening market, founded in 2015 in Hangzhou. The company offers two NMPA-approved non-invasive colorectal cancer screening tests — ColoClear (FIT-DNA, targeting 120 million high-risk individuals) and Pupu Tube (self-conducted FIT test, targeting 630 million) — and holds global rights to all its marketed and pipeline products including late-stage candidates for gastric and cervical cancer.
Summary
New Horizon Health is a Healthcare company based in Hangzhou, China, founded in 2015. It has raised $136.0M in total across 4 rounds, most recently a $30.0M Series E round in Jul 2020.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2021
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...